Newsroom Join our team About us Our purpose Our culture Products & pipeline Investors Making everyday life significantly better Discover our purpose Sharon, person with Parkinson’s, unstoppable on the court Adamas announces FDA approval for second indication for GOCOVRI as an adjunctive treatment to levodopa/carbidopa for Parkinson’s disease patients experiencing OFF episodes – Learn more At Adamas, we are passionate about improving lives and making a meaningful difference for people affected by neurological diseases. We leverage our experience in drug discovery, development and commercialization to deliver innovative medicines that reduce the burden on patients, caregivers, and society. About GOCOVRI We are focused on developing innovative medicines for neurological diseases. Learn more about our lead product. Learn more Our culture We are a team with a shared mission. We put patients first and keep them at the heart of all our decisions. Learn more Investors Access our Investor Hub to find important information about our company. Learn more Latest news Press release Adamas named 2021 finalist in the New Therapeutics category of the UCSF Health Awards October 1, 2021 Read more Media coverage Analyses: GOCOVRI works better to lessen OFF episodes, dyskinesia September 21, 2021 Parksinson’s News Today Read more Media coverage Parkinson’s medications: what is step therapy? September 12, 2021 Davis Phinney Foundation for Parkinson’s Read more Supporting the neurology community Our passion, commitment and connection to helping people affected by neurological diseases goes well beyond our office walls. Our work extends beyond the development and delivery of medicines – we are committed to playing an active role in the communities that we serve through advocacy and education programs, providing educational resources, and information to make a difference. We recognize the importance of integrating the many patient voice into all aspects of our work, and value our direct engagement with advocates and communities. Collaborations and partnerships are fundamental to how Adamas can help improve patients’ lives by filling unmet needs and make an impact through meaningful support to the organizations, initiatives, and causes that reflect our mission, values and strategic focus. Davis Phinney Foundation For Parkinson’s Adamas is a proud sponsor of the Davis Phinney Foundation and their Peak Partner program, which is focused on educating the Parkinson’s community about Parkinson’s motor complications, the impact of OFF and dyskinesia on people with Parkinson’s and care partners, and treatment options. Read a recent blog post about PD medications titled “What is step therapy”. Michael J. Fox Foundation for Parkinson’s Research Adamas is a proud partner and member of the Michael J. Fox Foundation (MJFF) Parkinson’s Disease Education Consortium, a network of multidisciplinary experts focused on improving patient and caregiver education and engagement to support better health outcomes for the Parkinson’s community. Adamas is also a sponsor of MJFF’s September 2021 spotlight on ‘OFF’ in Parkinson’s, establishing a comprehensive guide that helps community members navigate through education and resources. A recent blog post covered the definition of important PD terms, including ‘OFF’, as part of this educational campaign. American Parkinson Disease Association Adamas is happy to partner with the American Parkinson’s Disease Association (APDA), supporting important educational resources for the Parkinson’s community about motor complications. We are a proud sponsor of APDA’s ‘Info4U’ program, helping people with Parkinson’s better navigate their journey with Parkinson’s by arming them with a set of printed disease education materials included in a backpack. What’s new Adamas Pharma @AdamasPharmaNov 2 The World Biz 100 Innovation CEOs recognizes Adamas' CEO, Neil McFarlane, who is proud to lead a company in which every team member contributes to the Adamas mission and culture – our commitment to patients and innovation. Adamas Pharma @AdamasPharmaOct 1 #TeamAdamas CEO Neil McFarlane talks to @lifescileader1 about his career journey – the skills and lessons he’s learned along the way that help shape his leadership approach as a public pharma CEO. (h/t @RfwrightLSL) #patientsfirst #teamwork #Leadership Adamas Pharma @AdamasPharmaOct 1 We’re proud to be announced as a 2021 #UCSFHealthAwards2021 finalist in the New Therapeutics category! Co-sponsored by @BiocomCA,@ucsfhealthaward recognizes top therapeutics & technologies from California companies transforming healthcare: i... Connect with us Contact us Privacy policy Online tracking opt-out guide Terms of use Site map © 2021 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved. Please note that our Privacy Policy has recently been updated: Privacy PolicyACCEPT